R&D Systems™ Recombinant Human Activin RIIB Fc Chimera (Sf 21)

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The Recombinant Human Activin RIIB Fc Chimera (Sf 21) is derived from Sf 21 (baculovirus). The Recombinant Human Activin RIIB Fc Chimera (Sf 21) has been validated for the following applications: Bioactivity.

Specifications

• Formulation: Lyophilized from a 0.2μm filtered solution in PBS.
• Gene ID (Entrez): 93
• Molecular Weight (g/mol): 41 kDa (monomer)
• Name: Activin RIIB Fc Chimera
• Quantity: 100 μg
• Source: Spodoptera frugiperda,Sf 21 (baculovirus)-derived human Activin RIIB protein, (N-terminus) Met Human Activin RIIB (Ser19-Thr 134) Accession &Num; CAA54671.1 IEGRMD Human IgG1 (Pro100-Lys330) 6-His tag (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Structural Form: Disulfide-linked homodimer
• Endotoxin Concentration: <0.1 EU per 1μg of the protein by the LAL method.
• Gene Alias: activin A receptor, type IIB, Activin receptor type IIB, activin receptor type-2B, ActivinRIIB, ACTRIIB, ACTR-IIB, ACVR2B, EC 2.7.11, EC 2.7.11.30, MGC116908
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Purity or Quality Grade: 95%, by SDS-PAGE under reducing conditions and visualized by silver stain.